OZEMPIC Pen 1mg Novo Nordisk
Ozempic 1mg Pen—a Choice from Novo Nordisk for Better Blood Sugar Control
Achieving confident blood sugar management is possible with the Ozempic 1mg Pen from Novo Nordisk. This once-weekly injection contains semaglutide, a glucagon-like peptide-1 receptor agonist working synergistically within the body to balance insulin, curb appetite, and aid long-term weight regulation.
Key Benefits:
Clinically demonstrated reductions in hemoglobin A1c and weight through glycemic and appetite control
Convenience of a prefilled pen with no need for mixing or measuring individual doses
Weekly dosing designed for improved adherence to the treatment schedule
Potential reduction in major cardiovascular events in type 2 diabetes patients with established heart disease
Product Information:
Strength: 1mg semaglutide per dose
Quantity: Single prefilled injection pen
Manufacturer: Novo Nordisk
Administration: Subcutaneous injection into abdomen, thigh, or upper arm just beneath the skin
Patient Fit: Adults prescribed Ozempic for type 2 diabetes
Important Note:
Ozempic is a prescription medication. Always consult your healthcare provider before starting any new treatment, as Ozempic is not indicated for type 1 diabetes or diabetic ketoacidosis.